AAPL341.46+2.48 (+0.73%) ▲|ABBV265.12+0.64 (+0.24%) ▲|ABT104.16+1.18 (+1.15%) ▲|ACN184.00-2.11 (-1.13%) ▼|ADBE238.80-10.73 (-4.30%) ▼|AMAT468.84+4.60 (+0.99%) ▲|AMD618.55+3.03 (+0.49%) ▲|AMGN408.89+15.73 (+4.00%) ▲|AMT176.72+2.12 (+1.21%) ▲|AMZN254.50-3.96 (-1.53%) ▼|AVGO363.82+1.16 (+0.32%) ▲|AXP307.61-5.98 (-1.91%) ▼|BA197.84-3.32 (-1.65%) ▼|BAC56.47-1.49 (-2.57%) ▼|BKNG161.56-6.96 (-4.13%) ▼|BLK1,070.58-19.69 (-1.81%) ▼|BMY62.67+0.05 (+0.08%) ▲|BNY151.21-2.69 (-1.74%) ▼|BRK-B504.10+2.09 (+0.42%) ▲|C132.58-2.47 (-1.83%) ▼|CAT805.04-11.47 (-1.40%) ▼|CL87.02+0.76 (+0.88%) ▲|CMCSA22.71-0.23 (-0.98%) ▼|COF201.60-3.32 (-1.62%) ▼|COP126.60-0.93 (-0.73%) ▼|COST898.29-0.19 (-0.02%) ▼|CRM231.88-4.55 (-1.92%) ▼|CSCO104.98-6.48 (-5.81%) ▼|CVS87.61+0.01 (+0.01%) ▲|CVX204.21+0.54 (+0.27%) ▲|DE696.20+11.47 (+1.68%) ▲|DHR221.66+5.82 (+2.70%) ▲|DIS103.41-0.82 (-0.79%) ▼|DUK116.43-0.31 (-0.27%) ▼|EMR153.73+2.01 (+1.32%) ▲|FDX296.73+0.94 (+0.32%) ▲|GD343.49-10.41 (-2.94%) ▼|GE317.24-1.78 (-0.56%) ▼|GEV952.73+6.51 (+0.69%) ▲|GILD152.47+1.91 (+1.27%) ▲|GM83.83-0.13 (-0.15%) ▼|GOOG347.65-3.23 (-0.92%) ▼|GOOGL352.11-2.86 (-0.81%) ▼|GS947.37-12.02 (-1.25%) ▼|HD303.83+6.63 (+2.23%) ▲|HON211.01+4.53 (+2.19%) ▲|IBM231.00-0.93 (-0.40%) ▼|INTC121.78-0.01 (0.00%) ▼|INTU290.58-13.54 (-4.45%) ▼|ISRG400.91-0.75 (-0.19%) ▼|JNJ268.37-1.10 (-0.41%) ▼|JPM340.58-11.46 (-3.26%) ▼|KO88.41+1.29 (+1.48%) ▲|LIN464.42+6.92 (+1.51%) ▲|LLY1,170.51+5.62 (+0.48%) ▲|LMT519.95-15.45 (-2.89%) ▼|LOW195.49+4.51 (+2.36%) ▲|LRCX307.57+5.29 (+1.75%) ▲|MA558.85-8.80 (-1.55%) ▼|MCD250.68+2.80 (+1.13%) ▲|MDLZ60.96+0.79 (+1.31%) ▲|MDT91.41-0.34 (-0.37%) ▼|META739.61-1.64 (-0.22%) ▼|MMM167.72+2.75 (+1.67%) ▲|MO68.82+0.29 (+0.42%) ▲|MRK151.55+2.05 (+1.37%) ▲|MS200.46-5.66 (-2.75%) ▼|MSFT497.31-4.30 (-0.86%) ▼|MU1,083.30+39.34 (+3.77%) ▲|NEE79.58-0.06 (-0.07%) ▼|NFLX71.60-1.77 (-2.41%) ▼|NKE36.05-0.05 (-0.14%) ▼|NOW136.23-1.45 (-1.05%) ▼|NVDA228.82+1.44 (+0.63%) ▲|ORCL148.87+0.31 (+0.21%) ▲|PEP130.72+1.13 (+0.87%) ▲|PFE27.88+0.14 (+0.49%) ▲|PG147.62+1.54 (+1.05%) ▲|PLTR184.32+1.25 (+0.68%) ▲|PM190.41+2.93 (+1.56%) ▲|QCOM195.66+1.43 (+0.74%) ▲|RTX190.03-4.31 (-2.22%) ▼|SBUX95.44+0.54 (+0.56%) ▲|SCHW101.30-5.58 (-5.22%) ▼|SO85.26-0.20 (-0.23%) ▼|SPG205.67+0.69 (+0.33%) ▲|T25.11-0.34 (-1.34%) ▼|TMO658.77+0.01 (+0.00%) ▲|TMUS163.13-2.14 (-1.29%) ▼|TSLA377.99+2.78 (+0.74%) ▲|TXN270.00-0.88 (-0.32%) ▼|UBER70.38-0.47 (-0.66%) ▼|UNH374.17-3.40 (-0.90%) ▼|UNP273.60+3.97 (+1.47%) ▲|UPS96.04+1.29 (+1.36%) ▲|USB59.67-0.77 (-1.27%) ▼|V363.25-6.70 (-1.81%) ▼|VZ46.83-0.85 (-1.78%) ▼|WFC83.83-2.72 (-3.14%) ▼|WMT109.91+2.47 (+2.30%) ▲|XOM158.47+0.17 (+0.10%) ▲|AAPL341.46+2.48 (+0.73%) ▲|ABBV265.12+0.64 (+0.24%) ▲|ABT104.16+1.18 (+1.15%) ▲|ACN184.00-2.11 (-1.13%) ▼|ADBE238.80-10.73 (-4.30%) ▼|AMAT468.84+4.60 (+0.99%) ▲|AMD618.55+3.03 (+0.49%) ▲|AMGN408.89+15.73 (+4.00%) ▲|AMT176.72+2.12 (+1.21%) ▲|AMZN254.50-3.96 (-1.53%) ▼|AVGO363.82+1.16 (+0.32%) ▲|AXP307.61-5.98 (-1.91%) ▼|BA197.84-3.32 (-1.65%) ▼|BAC56.47-1.49 (-2.57%) ▼|BKNG161.56-6.96 (-4.13%) ▼|BLK1,070.58-19.69 (-1.81%) ▼|BMY62.67+0.05 (+0.08%) ▲|BNY151.21-2.69 (-1.74%) ▼|BRK-B504.10+2.09 (+0.42%) ▲|C132.58-2.47 (-1.83%) ▼|CAT805.04-11.47 (-1.40%) ▼|CL87.02+0.76 (+0.88%) ▲|CMCSA22.71-0.23 (-0.98%) ▼|COF201.60-3.32 (-1.62%) ▼|COP126.60-0.93 (-0.73%) ▼|COST898.29-0.19 (-0.02%) ▼|CRM231.88-4.55 (-1.92%) ▼|CSCO104.98-6.48 (-5.81%) ▼|CVS87.61+0.01 (+0.01%) ▲|CVX204.21+0.54 (+0.27%) ▲|DE696.20+11.47 (+1.68%) ▲|DHR221.66+5.82 (+2.70%) ▲|DIS103.41-0.82 (-0.79%) ▼|DUK116.43-0.31 (-0.27%) ▼|EMR153.73+2.01 (+1.32%) ▲|FDX296.73+0.94 (+0.32%) ▲|GD343.49-10.41 (-2.94%) ▼|GE317.24-1.78 (-0.56%) ▼|GEV952.73+6.51 (+0.69%) ▲|GILD152.47+1.91 (+1.27%) ▲|GM83.83-0.13 (-0.15%) ▼|GOOG347.65-3.23 (-0.92%) ▼|GOOGL352.11-2.86 (-0.81%) ▼|GS947.37-12.02 (-1.25%) ▼|HD303.83+6.63 (+2.23%) ▲|HON211.01+4.53 (+2.19%) ▲|IBM231.00-0.93 (-0.40%) ▼|INTC121.78-0.01 (0.00%) ▼|INTU290.58-13.54 (-4.45%) ▼|ISRG400.91-0.75 (-0.19%) ▼|JNJ268.37-1.10 (-0.41%) ▼|JPM340.58-11.46 (-3.26%) ▼|KO88.41+1.29 (+1.48%) ▲|LIN464.42+6.92 (+1.51%) ▲|LLY1,170.51+5.62 (+0.48%) ▲|LMT519.95-15.45 (-2.89%) ▼|LOW195.49+4.51 (+2.36%) ▲|LRCX307.57+5.29 (+1.75%) ▲|MA558.85-8.80 (-1.55%) ▼|MCD250.68+2.80 (+1.13%) ▲|MDLZ60.96+0.79 (+1.31%) ▲|MDT91.41-0.34 (-0.37%) ▼|META739.61-1.64 (-0.22%) ▼|MMM167.72+2.75 (+1.67%) ▲|MO68.82+0.29 (+0.42%) ▲|MRK151.55+2.05 (+1.37%) ▲|MS200.46-5.66 (-2.75%) ▼|MSFT497.31-4.30 (-0.86%) ▼|MU1,083.30+39.34 (+3.77%) ▲|NEE79.58-0.06 (-0.07%) ▼|NFLX71.60-1.77 (-2.41%) ▼|NKE36.05-0.05 (-0.14%) ▼|NOW136.23-1.45 (-1.05%) ▼|NVDA228.82+1.44 (+0.63%) ▲|ORCL148.87+0.31 (+0.21%) ▲|PEP130.72+1.13 (+0.87%) ▲|PFE27.88+0.14 (+0.49%) ▲|PG147.62+1.54 (+1.05%) ▲|PLTR184.32+1.25 (+0.68%) ▲|PM190.41+2.93 (+1.56%) ▲|QCOM195.66+1.43 (+0.74%) ▲|RTX190.03-4.31 (-2.22%) ▼|SBUX95.44+0.54 (+0.56%) ▲|SCHW101.30-5.58 (-5.22%) ▼|SO85.26-0.20 (-0.23%) ▼|SPG205.67+0.69 (+0.33%) ▲|T25.11-0.34 (-1.34%) ▼|TMO658.77+0.01 (+0.00%) ▲|TMUS163.13-2.14 (-1.29%) ▼|TSLA377.99+2.78 (+0.74%) ▲|TXN270.00-0.88 (-0.32%) ▼|UBER70.38-0.47 (-0.66%) ▼|UNH374.17-3.40 (-0.90%) ▼|UNP273.60+3.97 (+1.47%) ▲|UPS96.04+1.29 (+1.36%) ▲|USB59.67-0.77 (-1.27%) ▼|V363.25-6.70 (-1.81%) ▼|VZ46.83-0.85 (-1.78%) ▼|WFC83.83-2.72 (-3.14%) ▼|WMT109.91+2.47 (+2.30%) ▲|XOM158.47+0.17 (+0.10%) ▲|
19.5 C
New York
Tuesday, September 22, 2026

Tag: 6

newssourceFORcompanyinformationcontent1releasesmarket

Sprott Physical Platinum and Palladium Trust Updates Its “At-the-Market” Equity Program

TORONTO, June 12, 2025 (GLOBE NEWSWIRE) -- Sprott Asset Management LP (“Sprott Asset Management”), a subsidiary of Sprott Inc., on behalf of the Sprott Physical Platinum and Palladium Trust (NYSE: SPPP) (TSX: SPPP / SPPP.U) (the “Trust”), a closed-ended mutual fund trust created to invest and hold substantially all of its assets in physical platinum and palladium bullion, today announced that it has updated its at-the-market equity program to issue up to U.S.$100 million of units of the Trust (“Units”) in the United States and Canada.

Peak Energy expands Japan footprint with acquisition of 11 MW of high-voltage solar assets

Solar projects to come online by 2027 and enable corporates in Japan to decarbonize operations and save costs. SINGAPORE and TOKYO, June 13, 2025...

Scale Your Laser Engraving Business with Monport’s Mid-Year Deals on CO2 & Fiber Laser Machines

NEW YORK, June 12, 2025 /PRNewswire/ -- Monport laser has officially kicked off the Monport Mid-Year Super Sale, bringing the hottest deals of the...

DC Guaranteed Income Coalition Hosts Day of Action to Protect Critical Programs for DC Families

Event organized in response to DC Mayor Muriel Bowser cutting the Child Tax Credit for DC, Baby Bonds, Strong Families, Strong Futures pilot, and Early Childcare Funding from 2026 budget 
Event organized in response to DC Mayor Muriel Bowser cutting the Child Tax Credit for DC, Baby Bonds, Strong Families, Strong Futures pilot, and Early Childcare Funding from 2026 budget

SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Elevance

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Elevance To Contact Him Directly To Discuss Their Options

Santacruz Silver Reports First Quarter 2025 Results

VANCOUVER, BC, June 12, 2025 /CNW/ - Santacruz Silver Mining Ltd. (TSXV:SCZ) (OTCQB:SCZMF) (FSE:1SZ) ("Santacruz" or the "Company") reports its financial and operating results for...

Celldex Presents Unprecedented 76 Week Results from Barzolvolimab Phase 2 Study in Chronic Spontaneous Urticaria at EAACI Congress 2025

HAMPTON, N.J., June 12, 2025 (GLOBE NEWSWIRE) -- Celldex (NASDAQ:CLDX) announced today new data demonstrating profound, sustained complete response and improved quality of life at 76 weeks, 7 months after the completion of dosing with barzolvolimab in chronic spontaneous urticaria (CSU), an immune-related condition driven by mast cell activation. Barzolvolimab specifically targets mast cells by binding the receptor tyrosine kinase KIT with high specificity and potently inhibiting its activity, which is required for mast cell function and survival.

Blueprint Medicines Announces Data Reinforcing Sustained Clinical Efficacy and Well-Tolerated Safety Profile of Long-Term AYVAKIT®/AYVAKYT® (avapritinib) Treatment at 2025 EHA and EAACI Congresses

-- Breadth of presentations, including one oral and two flash talks, showcase Blueprint Medicines' leadership role in advancing care for patients with systemic mastocytosis...

Pulse Announces a $13.5 Million Seismic Data License Sale and Provides Revenue Update

CALGARY, Alberta, June 12, 2025 (GLOBE NEWSWIRE) -- Pulse Seismic Inc. (TSX:PSD) (OTCQX:PLSDF) (“Pulse” or the “Company”) is pleased to announce the sale of a significant seismic data license, valued at $13.5 million.

VSTS Investor Notice: Robbins LLP Reminds Investors of the Class Action Lawsuit Against Vestis Corporation

Robbins LLP is Investigating Allegations that Vestis Corporation (VSTS) Misled Investors regarding Customer Growth

Duke Energy Progress proposes new rates to support ongoing efforts to build a smarter energy future for South Carolina customers

Recent investments have strengthened the grid and reduced outages for customersCompany last requested a regulatory review of rates in 2022GREENVILLE, S.C., June 12, 2025...

Cancer Pain Market Set to Transform by 2034 Due to Launch of Breakthrough Therapies | DelveInsight

According to DelveInsight's analysis, the growth of the cancer pain market is expected to be mainly driven by increasing incidence and advances in disease...

Youth Serving Nonprofits Showcase Community Impact through Baltimore Children & Youth Fund’s 2025 Community Exhibition

BALTIMORE, June 12, 2025 /PRNewswire/ -- On June 3, over 250 community members, leaders, and mentors gathered at Baltimore Unity Hall for the Baltimore Children...

Daré Bioscience Announces Adjournment of Annual Meeting of Stockholders

Meeting to Reconvene on Wednesday, July 9, 2025 
Meeting to Reconvene on Wednesday, July 9, 2025

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTags6

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers